However, evidence indicates that these modifications, particularly at the TARDBP promoter, significantly influence TDP-43 levels, highlighting their potential implications for age-related neurodegeneration and ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.